Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 921.86 Billion JPY | 12.39% |
| 2023 | 820.2 Billion JPY | 16.62% |
| 2022 | 703.3 Billion JPY | 14.57% |
| 2021 | 613.84 Billion JPY | -2.39% |
| 2020 | 628.89 Billion JPY | 4.91% |
| 2019 | 599.48 Billion JPY | 1.99% |
| 2018 | 587.77 Billion JPY | 14.32% |
| 2017 | 514.16 Billion JPY | -2.07% |
| 2016 | 525.02 Billion JPY | 7.26% |
| 2015 | 489.5 Billion JPY | 4.74% |
| 2014 | 467.35 Billion JPY | 16.17% |
| 2013 | 402.29 Billion JPY | 4.04% |
| 2012 | 386.68 Billion JPY | 17.82% |
| 2011 | 328.21 Billion JPY | 3.86% |
| 2010 | 316 Billion JPY | 4.38% |
| 2009 | 302.74 Billion JPY | -1.19% |
| 2008 | 306.38 Billion JPY | 10.83% |
| 2007 | 276.43 Billion JPY | 11.9% |
| 2006 | 247.04 Billion JPY | 7.41% |
| 2005 | 230 Billion JPY | 6.88% |
| 2004 | 215.19 Billion JPY | 7.26% |
| 2003 | 200.62 Billion JPY | -99.89% |
| 2002 | 187082.1 Billion JPY | 106167.06% |
| 2001 | 176.04 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 238.91 Billion JPY | -0.07% |
| 2024 Q1 | 215.25 Billion JPY | 6.45% |
| 2024 Q2 | 228.62 Billion JPY | 6.21% |
| 2024 Q3 | 239.07 Billion JPY | 4.57% |
| 2024 FY | 921.86 Billion JPY | 12.39% |
| 2023 Q3 | 214.67 Billion JPY | 4.22% |
| 2023 Q1 | 197.34 Billion JPY | 9.74% |
| 2023 FY | 820.2 Billion JPY | 16.62% |
| 2023 Q4 | 202.21 Billion JPY | -5.8% |
| 2023 Q2 | 205.97 Billion JPY | 4.38% |
| 2022 Q3 | 178.84 Billion JPY | 3.43% |
| 2022 Q4 | 179.82 Billion JPY | 0.55% |
| 2022 Q1 | 171.71 Billion JPY | 3.94% |
| 2022 Q2 | 172.92 Billion JPY | 0.7% |
| 2022 FY | 703.3 Billion JPY | 14.57% |
| 2021 Q4 | 165.21 Billion JPY | -0.07% |
| 2021 FY | 613.84 Billion JPY | -2.39% |
| 2021 Q1 | 131.29 Billion JPY | -17.29% |
| 2021 Q2 | 151.99 Billion JPY | 15.77% |
| 2021 Q3 | 165.33 Billion JPY | 8.77% |
| 2020 Q2 | 154.75 Billion JPY | 1.46% |
| 2020 FY | 628.89 Billion JPY | 4.91% |
| 2020 Q4 | 158.75 Billion JPY | -2.53% |
| 2020 Q3 | 162.86 Billion JPY | 5.24% |
| 2020 Q1 | 152.52 Billion JPY | -2.15% |
| 2019 Q1 | 143.02 Billion JPY | -5.17% |
| 2019 FY | 599.48 Billion JPY | 1.99% |
| 2019 Q4 | 155.87 Billion JPY | -1.73% |
| 2019 Q3 | 158.61 Billion JPY | 11.72% |
| 2019 Q2 | 141.97 Billion JPY | -0.73% |
| 2018 Q3 | 152.34 Billion JPY | 4.85% |
| 2018 Q1 | 139.31 Billion JPY | -0.33% |
| 2018 FY | 587.77 Billion JPY | 14.32% |
| 2018 Q2 | 145.29 Billion JPY | 4.3% |
| 2018 Q4 | 150.82 Billion JPY | -1.0% |
| 2017 Q4 | 139.77 Billion JPY | 8.11% |
| 2017 Q3 | 129.28 Billion JPY | 7.21% |
| 2017 Q2 | 120.59 Billion JPY | -3.15% |
| 2017 FY | 514.16 Billion JPY | -2.07% |
| 2017 Q1 | 124.51 Billion JPY | -3.5% |
| 2016 FY | 525.02 Billion JPY | 7.26% |
| 2016 Q1 | 128.66 Billion JPY | 1.86% |
| 2016 Q2 | 130.5 Billion JPY | 1.44% |
| 2016 Q3 | 136.82 Billion JPY | 4.84% |
| 2016 Q4 | 129.03 Billion JPY | -5.69% |
| 2015 FY | 489.5 Billion JPY | 4.74% |
| 2015 Q3 | 129.89 Billion JPY | 9.74% |
| 2015 Q4 | 126.3 Billion JPY | -2.76% |
| 2015 Q1 | 114.94 Billion JPY | -5.86% |
| 2015 Q2 | 118.36 Billion JPY | 2.97% |
| 2014 Q3 | 119.23 Billion JPY | 3.74% |
| 2014 Q4 | 122.09 Billion JPY | 2.4% |
| 2014 FY | 467.35 Billion JPY | 16.17% |
| 2014 Q1 | 111.09 Billion JPY | 4.27% |
| 2014 Q2 | 114.93 Billion JPY | 3.46% |
| 2013 Q1 | 95.86 Billion JPY | -1.95% |
| 2013 Q4 | 106.54 Billion JPY | 2.53% |
| 2013 Q3 | 103.91 Billion JPY | 8.29% |
| 2013 Q2 | 95.96 Billion JPY | 0.1% |
| 2013 FY | 402.29 Billion JPY | 4.04% |
| 2012 Q1 | 95.63 Billion JPY | 13.88% |
| 2012 FY | 386.68 Billion JPY | 17.82% |
| 2012 Q2 | 95.08 Billion JPY | -0.57% |
| 2012 Q4 | 97.77 Billion JPY | -0.43% |
| 2012 Q3 | 98.19 Billion JPY | 3.27% |
| 2011 Q4 | 83.97 Billion JPY | 4.55% |
| 2011 FY | 328.21 Billion JPY | 3.86% |
| 2011 Q3 | 80.32 Billion JPY | -2.86% |
| 2011 Q2 | 82.68 Billion JPY | 1.78% |
| 2011 Q1 | 81.23 Billion JPY | 5.35% |
| 2010 Q1 | 77.46 Billion JPY | 8.77% |
| 2010 FY | 316 Billion JPY | 4.38% |
| 2010 Q3 | 80.83 Billion JPY | 0.3% |
| 2010 Q4 | 77.11 Billion JPY | -4.6% |
| 2010 Q2 | 80.59 Billion JPY | 4.04% |
| 2009 FY | 302.74 Billion JPY | -1.19% |
| 2009 Q4 | 71.22 Billion JPY | -4.42% |
| 2009 Q3 | 74.51 Billion JPY | -5.96% |
| 2009 Q2 | 79.23 Billion JPY | 0.0% |
| 2008 FY | 306.38 Billion JPY | 10.83% |
| 2007 FY | 276.43 Billion JPY | 11.9% |
| 2006 FY | 247.04 Billion JPY | 7.41% |
| 2005 FY | 230 Billion JPY | 6.88% |
| 2004 FY | 215.19 Billion JPY | 7.26% |
| 2003 FY | 200.62 Billion JPY | -99.89% |
| 2002 FY | 187082.1 Billion JPY | 106167.06% |
| 2001 FY | 176.04 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -28885079.701% |
| Ansell Limited | 1.61 Billion USD | -56829.723% |
| Ansell Limited | 1.61 Billion USD | -56829.723% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -499155.655% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -682583291.951% |
| Psykey, Inc. | 419.29 Thousand USD | -219858044.188% |
| ConvaTec Group Plc | 2.19 Billion USD | -41917.157% |
| ConvaTec Group Plc | 2.14 Billion USD | -42929.453% |
| Encision Inc. | 6.58 Million USD | -13997463.272% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -50515017.06% |
| LifePoint, Inc. | -18.5 Thousand USD | 4983043343.243% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -13530840.848% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -119412205.699% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -93474276.914% |
| Reflect Scientific, Inc. | 1.08 Million USD | -85345415.547% |
| SmileDirectClub, Inc. | 470.74 Million USD | -195731.483% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -49155.106% |
| SheerVision, Inc. | 3.49 Million USD | -26343306.183% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -66498276.246% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -123724455.19% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -884001127.429% |